Neurological complications after COVID-19

Types of patients: The patients after severe coronaviral infection with acquired pathology of the central nervous system, disorders of the cognitive functions of the brain, immunity and homeostasis disorders.

Therapy principle. The technology is underlain by the principle of a “nonrecoverable” brain, according to which all cells of the body are able to regenerate and self -restore, apart from the cells of the neural tissues of brain and spinal cord. Their ability for neurorestoration is very limited and their sanogenesis is only possible thanks to absorption of the donor cell systems and use of the damaged molecular structure of the nucleus material for restoration. Severe coronaviral infection often seriously damages the brain cortex, which is predominantly manifested by the cognitive disorders, such as memory, thinking, attention, volitional disorders and pronounced fatigue. This is mostly associated with autoimmune disorders induced by the aseptic inflammation in neuroglia of the brain. The process does not go as far as demyelination of the fibers, as it happens in multiple sclerosis and encephalomyelitis, the damage of the neurons and other neural cells has an organic character. Considering our concept of a “nonrecoverable” brain, intrathecal transfusions of the patient’s own non-manipulated and low-manipulated PBMCs can provide the solution. In case their molecular-biological damage is confirmed by the proteomic mapping and profiling, we propose their post-genome reconstruction by the co-incubation with therapeutic agent. However, the results are considerably more efficient if the technology is combined with the remote-controlled multi-wave radioneuroengineering of the brain (see Bioengineering of the brain).

Result. The effectiveness of the therapy of the post-covid syndrome increases by 1.5 to 2 times; memory, attention and emotional-volitional spheres recover within a month or a month and a half.